SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.53    -0.002 (-0.38%)
Bid:
0.51
Ask:
0.528
Spread: 0.018 (3.529%)
Market Cap: $308.10m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

TR1 Notification

10 Dec 2019 12:47

RNS Number : 3961W
Integrated Diagnostics Holdings PLC
10 December 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Integrated Diagnostic Holdings Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Intra-group reorganisation

X

3. Details of person subject to the notification obligationiv See Section 9

Name

Actis LLP

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Actis IDH B.V. (outgoing shareholder)

City and country of registered office (if applicable)

Amsterdam, The Netherlands

Name

Actis IDH Limited (incoming shareholder)

City and country of registered office (if applicable)

St Peter Port, Guernsey

5. Date on which the threshold was crossed or reachedvi:

06/12/2019

6. Date on which issuer notified (DD/MM/YYYY):

06/12/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

21.00%

0.00%

21.00%

150,000,000

Position of previous notification (if

applicable)

21.00%

0.00%

21.00%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ISIN: JE00BV9H9G76

31,500,000

0

21.00%

0.00%

SUBTOTAL 8. A

31,500,000

21.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 LP)

8.32%

0

8.32%

Actis Global 4 LP

8.32%

0

8.32%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 A LP)

2.67%

0

2.67%

Actis Global 4 A LP

2.67%

0

2.67%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 C LP)

0.83%

0

0.83%

Actis Global 4 C LP

0.83%

0

0.83%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Africa 4 LP)

4.54%

0

4.54%

Actis Africa 4 LP

4.54%

0

4.54%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Africa 4 A LP)

3.83%

0

3.83%

Actis Africa 4 A LP

3.83%

0

3.83%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis Guernsey GP Limited (as general partner of Actis 4 Co-Investment Scheme LP)

0.81%

0

0.81%

Actis 4 Co-Investment Scheme LP

0.81%

0

0.81%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

As announced on 31 December 2018 by Integrated Diagnostics Holdings plc, Actis IDH B.V., a holding company ultimately controlled by Actis GP LLP in its capacity as the General Partner of each of the limited partnerships comprising Actis Global 4 and Actis Africa 4, and which holds a 21% shareholding in the Integrated Diagnostics Holdings plc, has transferred its entire shareholding in Integrated Diagnostics Holdings plc to its affiliate, Actis IDH Limited, as result of an intra-group reorganisation. Actis IDH Limited is also ultimately controlled by Actis GP LLP.

 

Place of completion

Jersey

Date of completion

06/12/2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLBDBDDDSBBGCG
Date   Source Headline
12th May 20225:37 pmRNSAnnual Financial Report & Notice of AGM
21st Apr 20229:46 amRNSPreliminary Results
31st Mar 202210:04 amRNSIFC and IFC MENA Fund acquire 5% stake in IDH
29th Mar 20228:30 amRNSIDH launches fifth Al-Borg Scan Branch
1st Mar 20222:00 pmRNSDirectorate Change
20th Dec 202110:26 amRNSReplacement: IDH 50% Acquisition of IDC
20th Dec 20218:00 amRNSIDH Acquisition of Islamabad Diagnostic Centre
16th Nov 20217:00 amRNS3rd Quarter Results
12th Nov 202112:03 pmRNSNotice of Results
28th Oct 20214:34 pmRNSNotice of Arbitration
4th Oct 202111:48 amRNSIDH launches third Al-Borg Scan branch
24th Sep 202112:50 pmRNSIDH 1H 2021 Standalone Financial Statements
2nd Sep 20217:00 amRNSHalf-year Report
18th Aug 202110:04 amRNSBiolab to operate testing stations in QAIA
9th Jul 20214:16 pmRNSFinal dividend clarification
30th Jun 202112:21 pmRNSResult of AGM
17th Jun 202110:02 amRNSFinal Dividend Resolution – Date Amendments
7th Jun 20215:24 pmRNSAnnual Financial Report & Notice of AGM
7th Jun 20217:00 amRNSChange of Auditor
2nd Jun 20217:00 amRNS1st Quarter Results
27th May 20215:07 pmRNSShare Transfer Mechanism and Documents
25th May 20217:00 amRNSIDH partners with IFC on USD 45m debt financing
20th May 202111:58 amRNSIDH debuts trading on EGX
19th May 20217:00 amRNSFinal Results
6th May 20216:02 pmRNSFRA dual listing approval
5th May 202110:21 amRNSIDH EGX Dual Listing Approval
22nd Mar 202112:31 pmRNSDual Listing - FRA registration approval
18th Feb 202112:25 pmRNSTrading update for the year ended 31 December 2020
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Jan 20214:36 pmRNSPrice Monitoring Extension
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
29th Dec 20204:36 pmRNSPrice Monitoring Extension
23rd Dec 20201:35 pmRNSResults of EGM and Subdivision of Share Capital
4th Dec 20207:00 amRNSNotice of Extraordinary General Meeting
27th Nov 20204:36 pmRNSPrice Monitoring Extension
20th Nov 20204:40 pmRNSSecond Price Monitoring Extn
20th Nov 20204:35 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNS3rd Quarter Results
17th Nov 20204:00 pmRNSIDH exploring a possible dual listing
11th Nov 20207:00 amRNSNotice of Results
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSHalf-year Report
19th Aug 20205:16 pmRNSNotice of Results
16th Jul 20204:35 pmRNSPrice Monitoring Extension
23rd Jun 20204:26 pmRNSResult of AGM
12th Jun 20207:00 amRNSArrangements for 2020 AGM
2nd Jun 20207:00 amRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.